The structural network of inflammation and cancer: Merits and challenges

Seminars in Cancer Biology

Volumn 23, Issue 4, 2013, Pages 243-251

  Guven Maiorov, Emine ^a   Keskin, Ozlem ^a   Gursoy, Attila ^a   Nussinov, Ruth ^b,c,d  

^a KOÇ UNIVERSITY   (Turkey)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Inflammation; Inflammation and cancer link; MyD88; NF ?B; Structural data; Structural pathway; TLR

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CARCINOGENESIS; COMPUTER ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFLAMMATION; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MUTATIONAL ANALYSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 84881115846     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.05.003     Document Type: Review

References (68)

1. Mosca R., Ceol A., Aloy P. Interactome3D: adding structural details to protein networks. Nature Methods 2013, 10:47-53.
2. Tuncbag N., Gursoy A., Keskin O. Prediction of protein-protein interactions: unifying evolution and structure at protein interfaces. Physical Biology 2011, 8:035006.
3. Nussinov R., Tsai C.J. Allostery in disease and in drug discovery. Cell 2013, 153:293-305.
4. Nussinov R., Tsai C.J., Ma B. The underappreciated role of allostery in the cellular network. Annual Review of Biophysics 2013, 42:169-189.
5. Engin H.B., Keskin O., Nussinov R., Gursoy A. A strategy based on protein-protein interface motifs may help in identifying drug off-targets. Journal of Chemical Information and Modeling 2012, 52:2273-2286.
6. Kar G., Kuzu G., Keskin O., Gursoy A. Protein-protein interfaces integrated into interaction networks: implications on drug design. Current Pharmaceutical Design 2012, 18:4697-4705.
7. Nussinov R., Tsai C.J., Csermely P. Allo-network drugs: harnessing allostery in cellular networks. Trends in Pharmacological Sciences 2011, 32:686-693.
8. Szilagyi A., Nussinov R., Csermely P. Allo-network drugs: extension of the allosteric drug concept to protein-protein interaction and signaling networks. Current Topics in Medicinal Chemistry 2013, 13:64-77.
9. Kar G., Keskin O., Gursoy A., Nussinov R. Allostery and population shift in drug discovery. Current Opinion in Pharmacology 2010, 10:715-722.
10. Acuner Ozbabacan S.E., Gursoy A., Keskin O., Nussinov R. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery. Current Opinion in Drug Discovery & Development 2010, 13:527-537.
11. Csermely P., Korcsmaros T., Kiss H.J., London G., Nussinov R. Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review. Pharmacology & Therapeutics 2013, 138:333-408.
12. Keskin O., Ma B., Rogale K., Gunasekaran K., Nussinov R. Protein-protein interactions: organization, cooperativity and mapping in a bottom-up systems biology approach. Physical Biology 2005, 2:S24-S35.
13. Keskin O., Gursoy A., Ma B., Nussinov R. Principles of protein-protein interactions: what are the preferred ways for proteins to interact. Chemical Reviews 2008, 108:1225-1244.
14. Kiel C., Serrano L. Challenges ahead in signal transduction: MAPK as an example. Current Opinion in Biotechnology 2012, 23:305-314.
15. Acuner Ozbabacan S.E., Keskin O., Nussinov R., Gursoy A. Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes. Journal of Structural Biology 2012, 179:338-346.
16. Tuncbag N., Gursoy A., Nussinov R., Keskin O. Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM. Nature Protocols 2011, 6:1341-1354.
17. Ogmen U., Keskin O., Aytuna A.S., Nussinov R., Gursoy A. PRISM: protein interactions by structural matching. Nucleic Acids Research 2005, 33:W331-W336.
18. Trinchieri G. Inflammation in cancer: a therapeutic target?. Oncology (Williston Park) 2011, 25:418-420.
19. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
20. Chang Z.L. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflammation Research 2010, 59:791-808.
21. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annual Review of Immunology 2012, 30:677-706.
22. Tsan M.F. Toll-like receptors, inflammation and cancer. Seminars in Cancer Biology 2006, 16:32-37.
23. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254-258.
24. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
25. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow. Lancet 2001, 357:539-545.
26. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Molecular Cancer Research 2006, 4:221-233.
27. Mager D.L. Bacteria and cancer: cause, coincidence or cure? A review. Journal of Translational Medicine 2006, 4:14.
28. Balkwill F. Cancer and the chemokine network. Nature Reviews Cancer 2004, 4:540-550.
29. Mantovani A., Garlanda C., Allavena P. Molecular pathways and targets in cancer-related inflammation. Annals of Medicine 2010, 42:161-170.
30. Sparmann A., Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458.
31. Shchors K., Shchors E., Rostker F., Lawlor E.R., Brown-Swigart L., The Evan G.I. Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes & Development 2006, 20:2527-2538.
32. Phillips R.J., Mestas J., Gharaee-Kermani M., Burdick M.D., Sica A., Belperio J.A., et al. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. The Journal of Biological Chemistry 2005, 280:22473-22481.
33. Pages F., Galon J., Dieu-Nosjean M.C., Tartour E., Sautes-Fridman C., Fridman W.H. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010, 29:1093-1102.
34. Patil S., Pincas H., Seto J., Nudelman G., Nudelman I., Sealfon S.C. Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase. BMC Systems Biology 2010, 4:137.
35. Botos I., Segal D.M., Davies D.R. The structural biology of Toll-like receptors. Structure 2011, 19:447-459.
36. Cavalieri D., Rivero D., Beltrame L., Buschow S.I., Calura E., Rizzetto L., et al. DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cells. Immunome Research 2010, 6:10.
37. Jenkins K.A., Mansell A. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 2010, 49:237-244.
38. Kenny E.F., O'Neill L.A. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008, 43:342-349.
39. Dunne A., Ejdeback M., Ludidi P.L., O'Neill L.A., Gay N.J. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. The Journal of Biological Chemistry 2003, 278:41443-41451.
40. Valkov E., Stamp A., Dimaio F., Baker D., Verstak B., Roversi P., et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14879-14884.
41. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annual Review of Immunology 2002, 20:55-72.
42. Raza S., McDerment N., Lacaze P.A., Robertson K., Watterson S., Chen Y., et al. Construction of a large scale integrated map of macrophage pathogen recognition and effector systems. BMC Systems Biology 2010, 4:63.
43. Takeda K., Akira S. TLR signaling pathways. Seminars in Immunology 2004, 16:3-9.
44. Nunez Miguel R., Wong J., Westoll J.F., Brooks H.J., O'Neill L.A., Gay N.J., et al. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PloS ONE 2007, 2:e788.
45. Oshiumi H., Sasai M., Shida K., Fujita T., Matsumoto M., Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. The Journal of Biological Chemistry 2003, 278:49751-49762.
46. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nature Immunology 2008, 9:361-368.
47. He W., Liu Q., Wang L., Chen W., Li N., Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Molecular Immunology 2007, 44:2850-2859.
48. Kelly M.G., Alvero A.B., Chen R., Silasi D.A., Abrahams V.M., Chan S., et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Research 2006, 66:3859-3868.
49. Szajnik M., Szczepanski M.J., Czystowska M., Elishaev E., Mandapathil M., Nowak-Markwitz E., et al. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene 2009, 28:4353-4363.
50. Hue M., Riffle M., Vert J.P., Noble W.S. Large-scale prediction of protein-protein interactions from structures. BMC Bioinformatics 2010, 11:144.
51. Tyagi M., Hashimoto K., Shoemaker B.A., Wuchty S., Panchenko A.R. Large-scale mapping of human protein interactome using structural complexes. EMBO Reports 2012, 13:266-271.
52. Pons C., Grosdidier S., Solernou A., Perez-Cano L., Fernandez-Recio J. Present and future challenges and limitations in protein-protein docking. Proteins 2010, 78:95-108.
53. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nature Immunology 2007, 8:772-779.
54. Nguyen T., De Nardo D., Masendycz P., Hamilton J.A., Scholz G.M. Regulation of IRAK-1 activation by its C-terminal domain. Cellular Signalling 2009, 21:719-726.
55. Cloutier A., Guindi C., Larivee P., Dubois C.M., Amrani A., McDonald P.P. Inflammatory cytokine production by human neutrophils involves C/EBP transcription factors. Journal of Immunology 2009, 182:563-571.
56. Lynch V.J., May G., Wagner G.P. Regulatory evolution through divergence of a phosphoswitch in the transcription factor CEBPB. Nature 2011, 480:383-386.
57. Aytuna A.S., Gursoy A., Keskin O. Prediction of protein-protein interactions by combining structure and sequence conservation in protein interfaces. Bioinformatics 2005, 21:2850-2855.
58. Keskin O., Nussinov R. Similar binding sites and different partners: implications to shared proteins in cellular pathways. Structure 2007, 15:341-354.
59. Tsai C.J., Lin S.L., Wolfson H.J., Nussinov R. Protein-protein interfaces: architectures and interactions in protein-protein interfaces and in protein cores. Their similarities and differences. Critical Reviews in Biochemistry and Molecular Biology 1996, 31:127-152.
60. Bell R.E., Ben-Tal N. In silico identification of functional protein interfaces. Comparative and Functional Genomics 2003, 4:420-423.
61. Glaser F., Pupko T., Paz I., Bell R.E., Bechor-Shental D., Martz E., et al. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 2003, 19:163-164.
62. Tuncbag N., Kar G., Gursoy A., Keskin O., Nussinov R. Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Molecular Biosystems 2009, 5:1770-1778.
63. Kim P.M., Lu L.J., Xia Y., Gerstein M.B. Relating three-dimensional structures to protein networks provides evolutionary insights. Science 2006, 314:1938-1941.
64. Gursoy A., Keskin O., Nussinov R. Topological properties of protein interaction networks from a structural perspective. Biochemical Society Transactions 2008, 36:1398-1403.
65. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research 2000, 28:27-30.
66. Medzhitov R., Barton G.M. Toll-Like Receptor Pathway. Science Signaling 2013, (Connections Map in the Database of Cell Signaling, as seen 3 June 2013). http://stke.sciencemag.org/cgi/cm/stkecm;CMP_8643.
67. Shatsky M., Nussinov R., Wolfson H.J. A method for simultaneous alignment of multiple protein structures. Proteins 2004, 56:143-156.
68. Kuzu G., Keskin O., Gursoy A., Nussinov R. Constructing structural networks of signaling pathways on the proteome scale. Current Opinion in Structural Biology 2012, 22:367-377.